POSTER SESSION VI
Wednesday, March 11, 2009   —  1:00 PM - 4:00 PM
Hynes CC Exhibit Hall C/D


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GASTROINTESTINAL PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
82 Eosinophilic Esophagitis: Interobserver Variability in a Disease Entity in Which Counting Counts (557)
JF Busler, NP Patel, KF Geisinger, ID Hill, KR Geisinger - Wake Forest University School of Medicine, Winston-Salem, NC; University of Nebraska-Lincoln, Lincoln, NE 		Add
83 Stat6 Activation and Periostin Expression in Eosinophilic Esophagitis Versus Reflux Esophagitis (562)
WM Chandler, SK Kuwada, FC Clayton - University of Utah, Salt Lake City, UT 		Add
84 Histologic Characterization of Esophagitis Dissecans Superficialis (559)
SW Carmack, SJ Spechler, RM Genta - Dallas VA Medical Center, Dallas, TX; Caris Diagnostics, Irving, TX 		Add
85 Gastric Atrophy Diagnostic Accuracy: Comparison of OLGA with Baylor System (573)
HMT El-Zimaity, RH Riddell, S Abudayyeh, AR Opekun, DY Graham - McMaster University, Hamilton, ON, Canada; Mount Sinai Hospital, Toronto, ON, Canada; Baylor College of Medicine, Houston, TX 		Add
86 Helicobacter Pylori Detection in Gastric and Oral Mucosa (670)
ML Spencer, E Sepulveda, C Briceno, S Quilodran, U Brethauer, J Moreno, A Garcia - College of Dentistry, College of Medicine, Biological Sciences, Universidad de Concepcion, and Universidad Catolica Santisima, Concepcion, Concepcion, Chile 		Add
87 Detection of H. Pylori by PCR in Gastric Biopsies (609)
S Kiss, V Zsikla, M Baumann, C Triller, G Cathomas - Kantonales Institute for Pathology, Liestal, Switzerland 		Add
88 Histologic Mimics of Menetrier's Disease (692)
T Zuluaga Toro, RJ Coffey, WH Fiske, MK Washington - Vanderbilt University, Nashville, TN 		Add
89 Collagenous Gastritis - A Clinicopathological Study of Nineteen Cases (556)
IS Brown, NJ Carr, A Srivastava, GY Lauwers - Sullivan Nicolaides Pathology, Brisbane, Australia; Southern IML Pathology, Wollongong, Australia; Dartmouth Hitchcock Medical Centre, Lebanon, NH; Massachusetts General Hospital, Boston, MA 		Add
90 Surface Mitoses Are a Predictor of Cancer Progression in Barrett's Esophagus (567)
DP Coco, A Srivastava, CA Sanchez, X Li, D Cowan, BJ Reid, PL Blount, RD Odze - Brigham and Women's Hosptial, Boston, MA; Dartmouth Hitchcock Medical Center, Lebanon, NH; Fred Hutchinson Cancer Center, Seattle, WA; University of Washington, Seattle, WA 		Add
91 Mitosin Expression Is a Biomarker of Cancer Progression in Barrett's Esophagus (668)
G Soucy, DP Coco, JL Hornick, Q Huang, RD Odze - Brigham and Women's Hospital, Boston; Veterans Administration Hospital, Boston, MA 		Add
92 Loss of Neutrophil Gelatinase Associated Lipocalin Expression in Esophageal Adenocarcinoma Is Associated with Higher Pathologic Stage and Poor Survival (625)
DM Maru, AM Correa, Z Tong, H Wang, TT Wu, L Corley, S Krishnan, JA Ajani, SG Swisher, A Rashid, WL Hofstetter, S Guha - The University of Texas MD Anderson Cancer Center, Houston; Mayo Clinic, Rochester, NY 		Add
93 Anti-Phosphohistone H3 Shows Differential Expression in Barrett's Esophagus, Low-Grade Dysplasia, High-Grade Dysplasia, Adenocarcinoma Sequence (584)
M Goodarzi, AR Rashid, DM Maru - The University of Texas MD Anderson Cancer Center, Houston, TX 		Add
94 Expression of Insulin-Like Growth Factor II mRNA-Binding Protein 3 in Human Esophageal Adenocarcinoma and Its Precursor Lesions (576)
W Feng, CD Truong, J Zhai, Z Zhou, D Tan - The University of Texas MD Anderson Cancer Center, Houston, TX; The Methodist Hospital, Houston, TX; The University of Rochester, Rochester, NY 		Add
95 ProEx C Immunostain as a Marker for Dysplasia in Barrett's Esophagus (681)
GA Vincent, R Birbe, C Solomides, H Durra - Temple University Hospital, Philadelphia, PA 		Add
96 Outcome Analysis of 15-Year Follow-Up in a Regional Veterans Affairs Barrett's Esophagus Cohort with Respect to the Updated 2008 Guidelines for Surveillance (547)
S Askari, KK Dunning, BR Lindgren - Veterans Affairs Medical Center, Minneapolis, MN; University of Minnesota, Minneapolis, MN 		Add
97 Survival by Depth of Tumor Invasion in PT1 Esophageal Adenocarcinoma: An Analysis of 182 Patients (601)
DK Kaneshiro, JC Post, LA Rybicki, TW Rice, JR Goldblum - Cleveland Clinic, Cleveland, OH 		Add
98 Barrett's Esophagus in the Patients with Familial Adenomatous Polyposis (563)
M Chen, C Snyder, L Hatcher, HT Lynch, P Watson, Z Gatalica - Creighton University School of Medicine, Omaha, NE 		Add
99 HER2 Status in 146 Gastroesophageal Carcinomas Assessed by Two Rabbit Monoclonal Antibodies (SP3 and 4B5) and Two In Situ Hybridisation Methods (FISH and SISH) (554)
JE Boers, JC Meeuwissen, N Methorst - Isala Klinieken, Zwolle, Netherlands 		Add
100 Comparison between Biopsy-Based Diagnosis and Endoscopic Submucosal Dissection-Based Diagnosis of the Same Lesion in the Esophagus: Its Pitfall in a Diagnosis of Low-Grade Squamous Intraepithelial Neoplasia (633)
K Nagata, H Yamaguchi, U Motosugi, L Jin, S San-nohe, F Ogawa, Y Shimizu, T Sakurai, S-i Murat, M Yasuda, M Shimizu - Saitama Medical University International Medical Center, Hidaka, Saitama, Japan 		Add
101 Minichromosome Maintenance Protein 7 and SMAD 4 Expressions in Squamous Cell Carcinoma of the Esophagus (543)
JH Ahn, HK Chang - Kosin University College of Medicine, Gospel Hospital, Busan, Korea 		Add
102 SOX2 Is Highly Expressed in Squamous Cell Carcinomas of the Gastrointestinal Tract (622)
KB Long, JL Hornick - Brigham & Women's Hospital, Harvard Medical School, Boston, MA 		Add